Description
Market Report Coverage – Direct-to-Consumer Genetic Testing
Market Segmentation
• Product Type- Ancestry, Health and Wellness, and Entertainment
• Technology – Targeted Analysis, Single Nucleotide Polymorphisms (SNPs), and Whole Genome Sequencing (WGS)
• Distribution Channel- Online Channel and Over-the-Counter Channel
Regional Segmentation
• North America – U.S., Canada
• Europe– Germany, France, Italy, U.K., Spain, and Rest-of-Europe
• Asia-Pacific – China, Japan, Australia, India, and South Korea
• Latin America – Brazil, Mexico, and Rest-of-the-Latin America
• Rest-of-the-World
Market Growth Drivers
• Growing Number of Direct-to-Consumer Genetic Tests
• Decreasing Cost of Sequencing
• Increasing Research Funding in the Field of Molecular Biology
• Increase in Awareness and Acceptance of Personalized Medicines on a Global Level
Market Challenges
• Genomic Data Protection
• Uncertain Regulatory Standards for Direct-to-Consumer Genetic Tests
• Ethical and Social Issues
Market Opportunities
• Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
• Capitalizing on the High Prevalence of Genetic Disorders
• Growth in Emerging Nations
Key Companies Profiled
23andme Inc., 24Genetics, Ancestry.com LLC, Atlas Biomed, Color Genomics, DNAfit, Gene by Gene, Chengdu Twenty-Three Rubik’s Cube Biotechnology Co., Ltd., EasyDNA, Mapmygenome, MyHeritage Ltd., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., Konica Minolta, Inc., XCODE Life
Key Questions Answered in this Report:
• What are the major market drivers, challenges, and opportunities in the global direct-to-consumer genetic testing market?
• What are the key development strategies implemented by the major players in order to sustain in the competitive market?
• Which is the dominant product type developed by the leading and emerging of direct-to-consumer genetic testing market?
• What are the key technologies that have been used by leading players in the global market for the development of consumer genetic tests?
• How is each segment of the market expected to grow during the forecast period 2021-2031? The segments are:
o product type
o technology
o distribution channel
o geography
• Which companies are anticipated to be highly disruptive in the future, and why?
• What are the regulations for the development of direct-to-consumer genetic testing?
Market Overview
BIS Research healthcare experts have found the direct-to-consumer genetic testing market to be one of the growing markets, which is predicted to grow at a CAGR of 17.30% during the forecast period, 2021-2031. The direct-to-consumer genetic testing market’s growth has been primarily attributed to the major drivers in this market, such as growing number of direct-to-consumer genetic testing, increasing research funding in the field of molecular biology, and increase in awareness and acceptance of personalized medicine on a global level. However, genomic data protection, ethical and social issues, and lack of regulatory standards are some of the factors expected to restrain the market growth.
Decreased cost and time required for genetic sequencing has increased the acceptance of DTC genetic testing among the consumers. DTC genetic testing companies offer these genetic tests to their consumers through online channels and over-the-counter (OTC) channels, which has made these tests easily accessible to consumers around the globe.
The market is favored by the increased research activities based on next-generation sequencing-based technologies. The technology has been segmented into targeted analysis, whole genome sequencing, and single nucleotide polymorphisms. The whole genome sequencing segment is expected to grow at the highest CAGR of 17.37% during the forecast period 2021-2031. This increase is mainly attributed to a large number of research and development being conducted due to the COVID-19 pandemic and regulatory approvals gained by key companies for genetic health risks-based tests.
Within the research report, the market is segmented on the basis of product type, technology, distribution channel, and region. Each segment covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
With the increasing consumer awareness and intense market penetration, companies such as 23andme, Inc., Ancestry.com, LLC, and Color Genomics have become pioneers and significant competitors in this market.
Other key players in the market are 24Genetics, Easy DNA, DNAfit, and My Heritage Ltd., among others.
The increased demand for complex and custom sequencing techniques, rising genetic testing services, and growing research to treat and diagnose genetic and infectious diseases have opened opportunities for companies to expand their product portfolios, increase automation facilitation, and develop novel consumer genetics solutions by adopting different strategic approaches. Some of the strategies followed by the contributors are new product launches and enhancements, agreements, collaborations, partnerships, acquisitions, and expansions. For instance, in 2020, Eastern Biotech & Life Sciences launched Genoplan, which offers advanced genetic tests analyzing hundreds of medical, health, and well-being categories.
As the industry is new and currently unregulated, skepticism arises among government organizations and customers about the validity of the test results. Despite the good acceptance in some countries, few countries still require genetic counseling to be part of their mainstream genetic tests. Companies can collaborate with physicians and genetic counselors to analyze the genetic test results or to pre-test counseling to the customers. This could also lead to opening a new distribution channel of the market, therefore increasing the sales of these genetic tests.
The direct-to-consumer genetic testing market has been widely accepted in North America and some regions of Europe, such as the U.K. as well as in few parts of Asia-Pacific. Companies exploring regions such as the U.A.E, China, South Korea, and EU5 can open many business opportunities. Establishes players as well as new entrants should be focusing on shaping the regulatory landscape for the different countries and paving the way for entry into the regulated market, thus gaining the confidence of the consumers. Expanding globally will result in the explosion of the market.
Furthermore, established key players in the market should work with governments to organize education and awareness programs for consumers and genetic counselors for effective interpretation of results, providing consumers a sense of empowerment, which will certainly help the growth of the market. Due to the limited awareness among consumers and training among primary physicians or genetic counselors, there are high chances of misinterpretation of results and inappropriate test utilization. Professional support to the consumers will help the consumers to understand better about the outcomes and transform the reach of healthcare to the consumers.
Global Somatic Genetic Testing Market to Reach $16.79 Billion by 2030
Table of Contents
1 Product Definition
1.1 Inclusion and Exclusion
2 Market Scope
2.1 Scope of Work
2.2 Key Questions Answered in the Report
3 Research Methodology
3.1 Global Direct-to-Consumer Genetic Testing Market: Research Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model
3.5 Criteria for Company Profiling
4 Market Overview
4.1 Product Definition
4.1.1 Ancestry Tests
4.1.2 Health and Wellness Test
4.1.3 Entertainment Test
4.2 Direct-to-Consumer Genetic Testing Business Model
4.2.1 One-to-One
4.2.2 One-to-Many
4.3 Future Potential
4.4 COVID-19 Impact: Global Direct-to-Consumer Genetic Testing Market
5 Global Direct-to-Consumer Genetic Testing Market Regulatory Landscape
5.1 Legal Requirements and Regulations
5.2 Regulation in North America
5.2.1 U.S.
5.2.2 Canada
5.3 Regulation in Europe
5.3.1 Germany
5.3.2 France
5.3.3 U.K.
5.3.4 Italy
5.3.5 Spain
5.4 Regulation in APAC
5.4.1 China
5.4.2 Regulation in Japan
5.4.3 Australia
5.4.4 South-Korea
6 Market Dynamics
6.1 Impact Analysis
6.1.1 Growing Number of Direct-to-Consumer Genetic Tests
6.1.2 Increase in Awareness and Acceptance of Personalized Medicines on a Global Level
6.1.3 Decreasing Cost of Sequencing
6.1.4 Increasing Research Funding in the Field of Molecular Biology
6.2 Market Restraints
6.2.1 Genomic Data Protection
6.2.2 Uncertain Regulatory Standards for Direct-to-Consumer Genetic Tests
6.2.3 Ethical and Social Issues
6.3 Market Opportunity
6.3.1 Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
6.3.2 Capitalizing on the High Prevalence of Genetic Disorders
6.3.3 Growth in Emerging Nations
6.4 Key Trends
6.4.1 Curiosity Among Consumers
6.4.2 Increasing Public Awareness
6.4.3 Mushrooming Direct-to-Consumer Genetic Testing Services Market
6.4.4 Need for Precision Medicine
6.4.5 Hassle-Free Model
6.5 Key Strategies and Developments
6.5.1 Synergistic Activities
6.5.2 Approvals
6.5.3 Product Launches and Expansions
6.5.4 Acquisitions and Mergers
6.5.5 Funding
6.6 Market Share Analysis
7 Global Direct-to-Consumer Genetic Testing Market (by Technology), $Million, 2020-2031
7.1 Overview
7.2 Targeted Analysis
7.3 Single Nucleotide Polymorphism (SNPs)
7.4 Whole Genome Sequencing (WGS)
8 Global Direct to Consumer Genetic Testing Market (by Distribution Channel), $Million, 2020-2031
8.1 Overview
8.1.1 Online Channel
8.1.2 Over-the-Counter (OTC) Channel
9 Global Direct-to-Consumer Genetic Testing Market (by Product Type), $Million, 2020-2031
9.1 Ancestry
9.1.1 Genealogy
9.1.2 Relationship
9.2 Health and Wellness
9.2.1 Predictive Tests
9.2.2 Carrier Tests
9.2.3 Pharmacogenomics Tests
9.3 Entertainment
10 Global Direct-to-Consumer Genetic Testing Market (by Region), $Million, 2020-2031
10.1 North America
10.1.1 U.S.
10.1.2 Canada
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 U.K.
10.2.4 Italy
10.2.5 Spain
10.3 Asia-Pacific (APAC)
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Australia
10.4 Latin America
10.4.1 Brazil
10.4.2 Mexico
10.4.3 Rest-of-Latin America (RoLA)
10.5 Rest-of-the-World
11 Company Profiles
11.1 Overview
11.2 23andme Inc.
11.2.1 Company Overview
11.2.2 Role of 23andme Inc. in the Global Direct-to-Consumer Genetic Testing Market
11.2.3 Financials
11.2.4 Key Insights About Financial Health of the Company
11.2.5 SWOT Analysis
11.3 24Genetics
11.3.1 Company Overview
11.3.2 Role of 24Genetics in the Global Direct-to-Consumer Genetic Testing Market
11.3.3 SWOT Analysis
11.4 Ancestry.com LLC
11.4.1 Company Overview
11.4.2 Role of Ancestry.com LLC in the Global Direct-to-Consumer Genetic Testing Market
11.4.3 SWOT Analysis
11.5 Atlas Biomed
11.5.1 Company Overview
11.5.2 Role of Atlas Biomed in the Global Direct-to-Consumer Genetic Testing Market
11.5.3 SWOT Analysis
11.6 Color Genomics
11.6.1 Company Overview
11.6.2 Role of Color Genomics in the Global Direct-to-Consumer Genetic Testing Market
11.6.3 SWOT Analysis
11.7 DNAfit
11.7.1 Company Overview
11.7.2 Role of DNAfit in the Global Direct-to-Consumer Genetic Testing Market
11.7.3 SWOT Analysis
11.8 Gene by Gene
11.8.1 Company Overview
11.8.2 Role of Gene by Gene in the Global Direct-to-Consumer Genetic Testing Market
11.8.3 SWOT Analysis
11.9 Chengdu Twenty-Three Rubik’s Cube Biotechnology Co., Ltd.
11.9.1 Company Overview
11.9.2 Role of Twenty-Three Rubik’s Cube Biotechnology Co., Ltd. in the Global Direct-to-Consumer Genetic Testing Market
11.9.3 SWOT Analysis
11.1 EasyDNA
11.10.1 Company Overview
11.10.2 Role of EasyDNA in the Global Direct-to-Consumer Genetic Testing Market
11.10.3 SWOT Analysis
11.11 Mapmygenome
11.11.1 Company Overview:
11.11.2 Role of Mapmygenome India Ltd. in the Global Direct-to-Consumer Genetic Testing Market
11.11.3 SWOT Analysis
11.12 MyHeritage Ltd.
11.12.1 Company Overview
11.12.2 Role of MyHeritage Ltd. In the Global Direct-to-Consumer Genetic Testing Market
11.12.3 SWOT Analysis
11.13 Laboratory Corporation of America Holdings
11.13.1 Company Overview
11.13.2 Role of Laboratory Corporation of America Holdings in the Global Direct-to-Consumer Genetic Testing Market
11.13.3 Financials
11.13.4 SWOT Analysis
11.14 Myriad Genetics, Inc.
11.14.1 Company Overview
11.14.2 Role of Myriad Genetics, Inc. in the Global Direct-to-Consumer Genetic Testing Market
11.14.3 Financials
11.14.4 Key Insights About Financial Health of the Company
11.14.5 SWOT Analysis
11.15 Konica Minolta, Inc.
11.15.1 Company Overview
11.15.2 Role of Konica Minolta, Inc. in the Global Direct-to-Consumer Genetic Testing Market
11.15.3 Financials
11.15.4 Key Insights About Financial Health of the Company
11.15.5 SWOT Analysis
11.16 XCODE Life
11.16.1 Company Overview
11.16.2 Role of XCODE Life in the Global Direct-to-Consumer Genetic Testing Market
11.16.3 SWOT Analysis
List of Tables
Table 5.1: List of FDA-Approved Tests
Table 6.1: Likert Scale
Table 6.2: Impact Analysis of Market Drivers
Table 6.3: Impact Analysis of Market Restraints
List of Figures
Figure 1: Cumulative Number of Tested Conditions and Associated Genes for Genetic Testing, 2012-2019
Figure 2: Impact Analysis on the Global Direct-to-Consumer Genetic Testing Market
Figure 3: Global Direct-to-Consumer Genetic Testing Market (by Product Type), $Million, 2020 Vs. 2031
Figure 4: Global Direct-to-Consumer Genetic Testing Market (by Distribution Channel), $Million, 2020 Vs. 2031
Figure 5: Global Direct-to-Consumer Genetic Testing Market (by Technology), $Million, 2020 Vs. 2031
Figure 6: Global Direct-to-Consumer Genetic Testing Market Snapshot (by Region), $Million, 2020 and 2031
Figure 2.1: Global Direct-to-Consumer Genetic Testing Market Segmentation
Figure 3.1: Global Direct-to-Consumer Genetic Testing Market Methodology
Figure 4.1: Direct-to-Consumer Genetic Testing Market Workflow
Figure 4.2: Global Direct-to-Consumer Genetic Testing Market: COVID-19 Impact
Figure 6.1: Number of Direct-to-Consumer Genetic Tests Conducted, 2016-2021
Figure 6.2: Decreasing Cost and Increasing Output (Terabyte of Genome Sequencing, 2009-2025
Figure 6.3: Key Genetic Disorder Prevalence in the U.S., 2012-2019
Figure 6.4: Share of Key Strategies and Developments, January 2017 – June 2021
Figure 6.5: Synergistic Activities Share (by Company), January 2017-June 2021
Figure 6.6: Approvals Share (by Company), January 2017-March 2021
Figure 6.7: Product Launches, Enhancements, and Expansions Share (by Company), January 2017 – June 2021
Figure 6.8: Acquisitions and Mergers Share (by Company), January 2017 – June 2021
Figure 6.9: Funding Share (by Company), January 2017- June 2021
Figure 6.10: Market Share Analysis for Global Direct-to-Consumer Genetic Testing Market, 2020
Figure 7.1: Global Direct-to-Consumer Genetic Testing Market (by Technology), $Million, 2020-2031
Figure 7.2: Global Direct-to-Consumer Genetic Testing (DTC-GT) Market (Targeted Analysis), $Million, 2020-2031
Figure 7.3: Global Direct-to-Consumer Genetic Testing (DTC-GT) Market (Single Nucleotide Polymorphism), $Million, 2020-2031
Figure 7.4: Global Direct-to-Consumer Genetic Testing (DTC-GT) Market (Whole Genome Sequencing), $Million, 2020-2031
Figure 8.1: Global Direct-to-Consumer Genetic Testing Market (by Distribution Channel), $Million, 2020-2031
Figure 8.2: Global Direct-to-Consumer Genetic Testing (DT C-GT) Market (Online Channel), $Million, 2020-2031
Figure 8.3: Global Direct-to-Consumer Genetic Testing Market (OTC Channel), $Million, 2020-2031
Figure 9.1: Global Direct-to-Consumer Genetic Testing Market (by Product Type), $Million, 2020-2031
Figure 9.2: Global Direct-to-Consumer Genetic Testing Market (DTC-GT) Market (Ancestry), $Million, 2020-2031
Figure 9.3: Global Direct-to-Consumer Genetic Testing Market (Genealogy), $Million, 2020-2031
Figure 9.4: Global Direct-to-Consumer Genetic Testing Market (Relationship), $Million, 2020-2031
Figure 9.5: Global Direct-to-Consumer Genetic Testing Market (Health and Wellness), $Million, 2020-2031
Figure 9.6: Global Direct-to-Consumer Genetic Testing Market (Predictive Tests), $Million, 2020-2031
Figure 9.7: Global Direct-to-Consumer Genetic Testing Market (Carrier Tests), $Million, 2020-2031
Figure 9.8: Global Direct-to-Consumer Genetic Testing Market (Pharmacogenomics Tests), $Million, 2020-2031
Figure 9.9: Global Direct-to-Consumer Genetic Testing Market (Entertainment), $Million, 2020-2031
Figure 10.1: Global Direct-to-Consumer Genetic Testing Market (by Region), $Million, 2020-2031
Figure 10.2: North America Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.3: North America Direct-to-Consumer Genetic Testing Market (by Country), $Million, 2020-2031
Figure 10.4: U.S. Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.5: Canada Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.6: Europe Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.7: Europe Direct-to-Consumer Genetic Testing Market (by Country), $Million, 2020-2031
Figure 10.8: Germany Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.9: France Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.10: U.K. Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.11: Italy Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.12: Spain Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.13: Asia-Pacific (APAC) Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.14: China Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.15: Japan Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.16: India Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.17: South Korea Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.18: Australia Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.19: Latin America Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.20: Latin America Direct-to-Consumer Genetic Testing Market (by Country), $Million, 2020-2031
Figure 10.21: Brazil Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.22: Mexico Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.23: RoLA Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 10.24: Rest-of-the-World Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
Figure 11.1: Share of Key Company Profiles
Figure 11.2: 23andMe, Inc.: Overall Product Portfolio
Figure 11.3: 23andMe: Overall Financials, 2019-2020
Figure 11.4: 23andMe: Revenue (by Segment), 2019-2020
Figure 11.5: 23andMe: R&D Expenditure, 2019-2020
Figure 11.6: 23andme Inc.: SWOT Analysis
Figure 11.7: 24Genetics.: Overall Product Portfolio
Figure 11.8: 24Genetics: SWOT Analysis
Figure 11.9: Ancestry.com LLC.: Overall Product Portfolio
Figure 11.10: Ancestry.com LLC: SWOT Analysis
Figure 11.11: Atlas Biomed: Overall Product Portfolio
Figure 11.12: Atlas Biomed: SWOT Analysis
Figure 11.13: Color Genomics: Overall Product Portfolio
Figure 11.14: Color Genomics: SWOT Analysis
Figure 11.15: DNAfit: Overall Product Offerings
Figure 11.16: DNAfit: SWOT Analysis
Figure 11.17: Gene by Gene: Overall Product Portfolio
Figure 11.18: Gene by Gene: SWOT Analysis
Figure 11.19: Twenty-Three Rubik’s Cube Biotechnology Co., Ltd.: Overall Product Portfolio
Figure 11.20: Chengdu Twenty-Three Rubik’s Cube Biotechnology Co., Ltd.: SWOT Analysis
Figure 11.21: EasyDNA: Overall Product Portfolio
Figure 11.22: EasyDNA: SWOT Analysis
Figure 11.23: Mapmygenome India Ltd.: Overall Product Portfolio
Figure 11.24: Mapmygenome: SWOT Analysis
Figure 11.25: MyHeritage Ltd: Overall Product Portfolio
Figure 11.26: MyHeritage Ltd.: SWOT Analysis
Figure 11.27: Laboratory Corporation of America Holdings: Portfolio
Figure 11.28: Laboratory Corporation of America Holdings: Overall Financials, 2018-2020
Figure 11.29: Laboratory Corporation of America Holdings: Revenue (by Segment), 2018-2020
Figure 11.30: Laboratory Corporation of America Holdings: Revenue (by Region), 2020
Figure 11.31: Laboratory Corporation of America Holdings: SWOT Analysis
Figure 11.32: Myriad Genetics, Inc.: Product Portfolio
Figure 11.33: Myriad Genetics, Inc.: Overall Financials, 2018-2020
Figure 11.34: Myriad Genetics, Inc.: Revenue (by Business Segment), 2018-2020
Figure 11.35: Myriad Genetics, Inc.: R&D Expenditure, 2018-2020
Figure 11.36: Myriad Genetics, Inc.: SWOT Analysis
Figure 11.37: Konica Minolta, Inc: Product portfolio
Figure 11.38: Konica Minolta, Inc.: Overall Financials, 2017-2019
Figure 11.39: Konica Minolta, Inc.: Revenue (by Business Segment), 2017-2019
Figure 11.40: Konica Minolta, Inc.: Regional revenue, 2017-2019
Figure 11.41: Konica Minolta, Inc.: R&D Expenditure, 2017-2019
Figure 11.42: Konica Minolta, Inc: SWOT Analysis
Figure 11.43: XCODE Life: Overall Product Portfolio
Figure 11.44: XCODE Life: SWOT Analysis
